Valuation: Genmab A/S

Market Cap 119B 18.37B 15.92B 14.9B 13.6B 25.59B 1,752B 26.02B 175B 68.46B 877B 68.96B 67.46B 2,925B P/E 2026 *
25.2x
P/E 2027 * 17.8x
Enterprise Value 139B 21.4B 18.55B 17.36B 15.84B 29.81B 2,041B 30.31B 204B 79.76B 1,022B 80.36B 78.6B 3,409B EV / Sales 2026 *
4.78x
EV / Sales 2027 * 3.87x
Free-Float
95.41%
Yield 2026 *
-
Yield 2027 * -
1 day+0.05%
1 week+6.12%
Current month+7.24%
1 month+6.66%
3 months+20.13%
6 months+5.93%
Current year-1.68%
1 week 1,877
Extreme 1877
2,066
1 month 1,819.5
Extreme 1819.5
2,066
Current year 1,512
Extreme 1512
2,257
1 year 1,396
Extreme 1396
2,257
3 years 1,157
Extreme 1157
2,710
5 years 1,157
Extreme 1157
3,327
10 years 786.2
Extreme 786.2
3,327
Manager TitleAgeSince
Chief Executive Officer 65 2010-05-31
Director of Finance/CFO 48 2020-02-29
Chief Tech/Sci/R&D Officer - 2024-08-15
Director TitleAgeSince
Director/Board Member 75 2003-10-31
Director/Board Member 58 2014-12-31
Director/Board Member 75 2014-12-31
Date Insider Type Main position Quantity % Market Cap.
12/1/25 Fiscal year

Director

189 0.0003%
12/1/25 Fiscal year

Director

189 0.0003%
12/1/25 Fiscal year

Director

283 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+0.05%+6.12%+46.81%-21.81% 18.37B
-0.70%+13.34%+75.61%+103.83% 70.51B
-2.35%+2.88%+35.39%+64.72% 54.05B
-1.62%+34.25%+17.43%+491.04% 28.95B
-1.09%+11.92%+53.79%+6.84% 24.05B
0.00%+1.59%-15.06%-13.21% 23.31B
+9.77%+20.16%+260.17%+472.38% 18.67B
-0.19%+7.26%+30.70%+622.60% 16.1B
-3.08%-8.34%+37.21%+138.52% 12.72B
+1.03%-0.39%+418.54%+209.32% 12.61B
Average +0.18%+364.77%+96.06%+207.42% 27.93B
Weighted average by Cap. -0.35%+338.30%+73.93%+170.88%

Financials

2026 *2027 *
Net sales 28.99B 4.48B 3.88B 3.63B 3.31B 6.23B 427B 6.34B 42.57B 16.68B 214B 16.8B 16.44B 713B 33.66B 5.2B 4.5B 4.22B 3.85B 7.24B 496B 7.36B 49.43B 19.37B 248B 19.51B 19.08B 828B
Net income 4.94B 763M 661M 619M 565M 1.06B 72.75B 1.08B 7.26B 2.84B 36.41B 2.86B 2.8B 121B 7.14B 1.1B 955M 894M 815M 1.53B 105B 1.56B 10.48B 4.11B 52.59B 4.14B 4.05B 175B
Net Debt 19.66B 3.03B 2.63B 2.46B 2.25B 4.23B 289B 4.3B 28.86B 11.31B 145B 11.39B 11.14B 483B 11.22B 1.73B 1.5B 1.41B 1.28B 2.41B 165B 2.45B 16.48B 6.46B 82.71B 6.51B 6.36B 276B
Logo Genmab A/S
Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows: - royalties (83.4%); - income from sales of products (10.7%); - other (5.9%): primarily income from partnership agreement. Net sales are distributed geographically as follows: Denmark (89.4%), the United States (4.9%) and Japan (5.7%).
Employees
3,119
Date Price Change Volume
26-08-11 DKK 1,993.00 +0.05% 87,351
26-08-10 DKK 1,992.00 -0.35% 129,558
26-08-07 DKK 1,999.00 +6.50% 316,139
26-08-06 DKK 1,877.00 -0.79% 90,714
26-08-05 DKK 1,892.00 +0.75% 94,097
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
1,993.00DKK
Average target price
2,403.92DKK
Spread / Average Target
+20.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GMAB Stock